What is Empower Clinics Inc. (EPWCF)?

Empower Clinics Inc. (EPWCF) is a stock in the Healthcare sector, Medical - Care Facilities industry. View full analysis on Stocks360.

What is the current price of EPWCF?

The current price of EPWCF is $0.00. Prices are updated in real time on Stocks360.

What is EPWCF's price-to-earnings (PE) ratio?

EPWCF's trailing twelve-month PE ratio is -0.00, based on current price and earnings per share data available on Stocks360.

What is EPWCF's market capitalization?

EPWCF's market capitalization is $2,535,550.00, placing it in the small-cap tier.

Empower Clinics Inc. (EPWCF)

Stock analysis · OTC · Healthcare · Medical - Care Facilities

$0.00

Market Cap

$2.54M

PE (TTM)

-0.00

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

2.06

Day Range

$0.00 – $0.00

52-wk Range

$0.00 – $0.00

Avg Volume

N/A

Volume

2.00

Empower Clinics Inc. (EPWCF) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $2.54M. Trailing PE -0.00. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Empower Clinics Inc.

Empower Clinics Inc. functions as a comprehensive healthcare provider, delivering integrated wellness services that address both physical and mental well-being. Patients receive care through various channels, including digital platforms, telemedicine consultations, and advanced medical diagnostics laboratories, catering to populations across the United States and Canada. The company is actively developing a network, with 33 clinics in its pipeline, located in the Canadian provinces of Alberta, British Columbia, and New Brunswick. Additionally, Empower Clinics has formed a strategic partnership with SoLVBL Solutions Inc. to create secure data management solutions for its diagnostic testing processes. The firm's corporate headquarters are situated in Vancouver, Canada.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-0.00×
P/S (TTM)	0.54×
P/B	-0.00×
P/FCF (TTM)	-600.38×
EV / EBITDA	-6.72×
EV / Sales	1.57×
Earnings Yield	-40.25%
Free Cash Flow Yield	-0.17%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$7.32M
Revenue (TTM)	$4.66M
Net Income (TTM)	-$1.02M
Free Cash Flow (TTM)	$1.49M
Net Debt	$4.78M
Working Capital	-$3.93M
Gross Margin	42.21%
Operating Margin	-106.26%
Net Margin	-0.06%
Return on Equity	0.04%
Return on Invested Capital	403.20%